Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy

Kiyoshi Moriyama, Koji Uzawa, Takehiko Iijima, Mariko Kotani, Kumi Moriyama, Yuki Ohashi, Toru Satoh, Tomoko Yorozu

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The perioperative management of pulmonary hypertension in a patient with Eisenmenger syndrome, the most advanced form of associated pulmonary artery hypertension (PAH), who required a sigmoidectomy is presented. The treatment for pulmonary hypertension was switched from oral sildenafil to intravenous epoprostenol to avoid the unexpected discontinuation of vasodilation during the perioperative period. The scheduled perioperative conversion should be considered for patients with severe PAH undergoing major abdominal surgery to ensure the stabilization of pulmonary and systemic hemodynamics.

Original languageEnglish
Pages (from-to)487-489
Number of pages3
JournalJournal of Clinical Anesthesia
Volume24
Issue number6
DOIs
Publication statusPublished - 2012 Sep
Externally publishedYes

Keywords

  • Eisenmenger syndrome
  • Epoprostenol
  • Sigmoidectomy
  • Sildenafil

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy'. Together they form a unique fingerprint.

Cite this